专利检索 ap:("BRISTOL-MYERS SQUIBB COMPANY") AND inv:"Brian J. SCHMDIT" 第 1 页

1.

发明公开
DOSING AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CTLA-4 ANTIBODY AS MONOTHERAPY 审中-公开

公开(公告)号：US20240002513A1

公开(公告)日：2024-01-04

申请号：US18251935

申请日：2021-11-05

申请人： BRISTOL-MYERS SQUIBB COMPANY

发明人： Leonard P. JAMES , Yougan CHENG , Brian J. SCHMDIT , John J. ENGELHARDT , Li LI

IPC分类号： C07K16/28

CPC分类号： C07K16/2818 , C07K2317/41 , A61K2039/545

摘要： The present invention provides methods of dosing and administration of non-fucosylated anti-CTLA-4 antibodies, such as non-fucosylated ipilimumab, as monotherapy, and related compositions and dosage forms.